BioSpace News Archive

Government

Medical Journal Refuses to Retract Vaccine Study Despite RFK Jr.’s Criticism

The Annals of Internal Medicine ran a large-scale study in July, pointing to the lack of an association between childhood aluminum exposure through vaccination and chronic conditions. The Health Secretary, in an opinion piece earlier this month, called the paper a “ballyhooed study.”

August 12, 2025

·

2 min read

·

Tristan Manalac

View from above of male hand interfering collapsing dominos in a conceptual image of business crisis management. Over navy blue background.

Vaccines

HHS Freezes Vaxart’s Oral COVID-19 Vaccine, Again

The stop order came on Aug. 5, the same day Health Secretary Robert F. Kennedy Jr. terminated 22 mRNA vaccine projects under the Biomedical Advanced Research and Development Authority, though Vaxart’s candidate is protein-based.

August 12, 2025

·

2 min read

·

Tristan Manalac

Cancer

Bayer Makes Potential $1.3B Cancer Bet in Kumquat Deal

For $1.3 billion in aggregate—including upfront and milestone payments—Bayer will get exclusive global access to Kumquat Biosciences’ small-molecule KRAS G12D blocker.

August 12, 2025

·

2 min read

·

Tristan Manalac

C-suite

Caught In Sarepta ‘Downdraft,’ Arrowhead Becomes RNAi Knight in Shining Armor

Sarepta’s troubles had nothing to do with Arrowhead’s assets, and yet both companies have seen their stock prices decline this past month. BioSpace caught up with Arrowhead’s Chris Anzalone to talk about the biotech’s role as an RNAi pipeline savior.

August 12, 2025

·

7 min read

·

Annalee Armstrong

Dismissal of an incompetent employee. Refuse to participate, low morale. Nonconformist. Open for new possibilities and opportunities. Quit the job.

Government

Top ARPA-H Official Departs in Protest of BARDA mRNA Cuts

Alastair Thomson, chief data officer at the HHS sub-agency, announced his resignation in opposition to Health Secretary Robert F. Kennedy Jr.'s “stupid” decision to cancel $500 million worth of contracts focused on mRNA technology.

August 12, 2025

·

1 min read

·

Dan Samorodnitsky

Isometric projection of a medieval castle on an island

Manufacturing

Obesity Leaders Dig Manufacturing Moats To Defend Injectable GLP-1 Empires

Leaders at Eli Lilly believe heavy investment in the company’s manufacturing footprint “sets a high standard that newcomers may find challenging to match.” At least one of those newcomers disagrees.

August 12, 2025

·

6 min read

·

Nick Paul Taylor

Press Releases

I-Mab Completes Enrollment in Planned Phase 1b Dose Expansion Study for Givastomig in Combination with Immunochemotherapy in Patients with 1L Gastric Cancers

August 12, 2025

·

6 min read

Press Releases

Madrigal Pharmaceuticals to Participate in the Canaccord Genuity 45th Annual Growth Conference